Sphingosine inhibits calcium release from sarcoplasmic reticulum membranes.
Betto
R
R
CNR Unit for muscle Biology and Physiopathology, University of Padova, Italy.
Teresi
A
A
Fachechi-Cassano
G
G
Salviati
G
G
Sabbadini
R A
RA
D019307:1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; D000818:Animals; D002110:Caffeine / Q000494:pharmacology; D002118:Calcium / Q000378:metabolism*; D066298:In Vitro Techniques; D007546:Isoquinolines / Q000494:pharmacology; D007700:Kinetics; D009132:Muscles / Q000187:drug effects / Q000378:metabolism*; D010879:Piperazines / Q000494:pharmacology; D047428:Protein Kinase Inhibitors; D011817:Rabbits; D012519:Sarcoplasmic Reticulum / Q000187:drug effects / Q000378:metabolism*; D013110:Sphingosine / Q000494:pharmacology*
D007546:Isoquinolines; D010879:Piperazines; D047428:Protein Kinase Inhibitors; D002110:Caffeine; D019307:1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; D013110:Sphingosine; D002118:Calcium